CAR T-cell vs bispecific antibodies in relapsed/refractory mantle cell lymphoma: a systematic review and meta-analysis. [PDF]
Li MJ +9 more
europepmc +1 more source
Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies. [PDF]
Cederlund A +6 more
europepmc +1 more source
Fulminant Mantle Cell Lymphoma Presenting With Hepatic Infiltration and Spontaneous Tumor Lysis Syndrome. [PDF]
Sheth S, Alsamman A.
europepmc +1 more source
Contemporary Treatment and Survival Outcomes in Mantle Cell Lymphoma: A National Real-World Analysis From REALYSA, a LYSA Cohort. [PDF]
Cheminant M +33 more
europepmc +1 more source
Leukemic Non-Nodal Mantle Cell Lymphoma Presenting with Traumatic Splenic Rupture. [PDF]
Haque M, Amraei R, Rozenova KA.
europepmc +1 more source
First Case of Concurrent Cytomegalovirus and <i>Aspergillus tamarii</i> Pulmonary Infections in a Mantle Cell Lymphoma Patient: A Case Report and Literature Review. [PDF]
Zhong L, Yuan K.
europepmc +1 more source
Updates of CSCO guidelines for diagnosis and treatment of lymphoma: 2026 edition. [PDF]
Liu W, Zhao D, Ma J, Zhu J, Song Y.
europepmc +1 more source
Response alone does not define optimal bridging before brexucabtagene autoleucel in mantle cell lymphoma. [PDF]
Zhang M, Chen Y.
europepmc +1 more source
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy With Subsequent Diagnosis of Mantle Cell Lymphoma. [PDF]
Zhao C, Duffield A, Toz B.
europepmc +1 more source
Cutaneous Acral Presentation of Indolent Mantle Cell Lymphoma With Prominent Nail Involvement and Atypical Immunophenotype. [PDF]
Sun QW +5 more
europepmc +1 more source

